Search Results

Site Search

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 30), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...

Labor Day specimen shipment alert - Insights

Due to the Labor Day holiday (recognized on Monday, September 6), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.

Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunity - Insights

This “Specialty Testing” webinar will discuss the collaborative effort which led to the discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.

Pediatric CNS Disorder Evaluations [Test in Focus] - Insights

Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when...

MCL Cytogenetics Tech Only HER2 Paraffin Testing Patient Information MC1235203

MCL Cytogenetics Tech HER2 Paraffin Testing Patient Information Complete print Cytogenetics Tech HER2 Paraffin Testing Patient Information Patient Information Patient Middle Patient ID

Sarcoma Informative Cases - Insights

Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue.  With numerous subtypes of sarcoma that can

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Next-generation sequencing: Examining an often oversimplified & misunderstood technology - Part III - Insights

With the rise of next generation sequencing (NGS) technology, multigene panel testing is expanding so rapidly that clinical practice is racing to keep pace. And questions within genetic tests have expanded along with it, making definitive...